KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD has a total of 36 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CTI BIOPHARMA CORP, IDORSIA PHARMACEUTICALS LTD and CENTAURUS BIOPHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 4 | |
#4 | Republic of Korea | 4 | |
#5 | Brazil | 3 | |
#6 | China | 3 | |
#7 | United States | 3 | |
#8 | Hong Kong | 2 | |
#9 | Israel | 2 | |
#10 | New Zealand | 2 | |
#11 | WIPO (World Intellectual Property Organization) | 2 | |
#12 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Somepalli Venkateswarlu | 30 |
#2 | Gokaraju Rama Raju | 30 |
#3 | Kasina Sudhakar | 30 |
#4 | Golakoti Trimurtulu | 25 |
#5 | Gokaraju Ganga Raju | 25 |
#6 | Bhupathiraju Kiran | 24 |
#7 | Sengupta Krishanu | 22 |
#8 | Alluri Venkata Krishna Raju | 20 |
#9 | Gokaraju Venkata Kanaka Ranga Raju | 20 |
#10 | Abrams Paul G | 6 |
Publication | Filing date | Title |
---|---|---|
US2014086837A1 | F-18 radiolabeled compounds for diagnosing and monitoring kidney function | |
US2013287767A1 | Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof | |
EP2648509A2 | Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof | |
BR112013011689A2 | compounds and methods of use of substituted 4- (selenophen-2 (or 3) -ylamino) pyrimidine | |
AU2010243213A1 | Anti-cancer drugs, and uses relating for malignant melanoma and other cancers |